On Monday morning, Pfizer-BioNTech announced that a low dose of its COVID-19 vaccine is safe for children ages 5 through 11 and could arrive by late October if approved by the Food and Drug Administration.

For Allegheny County parents, that news couldn’t come soon enough amid reports of rising pediatric infections across the region and country.

“I see that news and I get excited, but that’s still 6 weeks-ish away, and I wish it was next week,” said Alicia Schisler, whose twin daughter and son are 8 years old and unvaccinated.

“It feels like we’re all playing a game of COVID keep-away.”

Advertise with us

Pfizer’s vaccine data must first be submitted to the FDA, which said in a statement that it hopes to do so by the end of the month. Then, the vaccine must pass through regulators to determine its safety and efficiency — a process that could take up to a month.

According to Pfizer, the vaccine — with one-third of the amount normally administered to adults and teens — triggered a robust immune response in children as young as 5.

The news comes as children in Allegheny County have returned to classrooms, albeit with masks and social distancing guidelines ordered by Pennsylvania Gov. Tom Wolf. While masks lower the risk of infection, Allegheny County has recorded 12,240 COVID-19 cases in children under 18 since the beginning of the pandemic. According to county health data, 12% of infections in August were made up of children 12 and under.

“This is an announcement many of us, parents and otherwise, have been eagerly awaiting for the last few months,” said Dr. Andrew Nowalk, clinical director in the Division of Infectious Diseases at UPMC Children's Hospital. “This is a really important announcement, because right now, that 5- to 11-year-old group is completely unvaccinated in the United States, getting together in school and spreading the delta [variant of the] virus.”

“We’ve had over 500 children die in the United States — that we know of — from COVID so far,” Dr. Nowalk added. “That’s a really unacceptable death toll.”

Advertise with us

4 steps to COVID-19 vaccine for kids

When Ms. Schisler first heard from Mt. Lebanon School District that the vaccine was authorized for children 12 and up, she took her older son, Jack, to the district vaccination clinic within a day — “I had tears in my eyes of relief,” she said.

After the news from Pfizer, she won’t hesitate with twins Maddie and Jamie, 8, either.

“For me, it’s a no-brainer — my children will be vaccinated as soon as the vaccine becomes available,” Ms. Schisler said.

For her, navigating the last 18 months as a parent has been a rollercoaster — and the vaccine is a sign of relief.

“They were in first grade when all of this started, and now they’re in third grade,” Ms. Schisler said of her twins, who attend Markham Elementary School. “It’s crazy the amount of time that has passed, and it has been incredibly challenging.

Advertise with us

“I think so many parents, doing school at home while you’re working full time remotely, all being in the house, is really hard. Some really hard days, for both adults and kids.”

A vaccine for young children could also put an end to some of parents’ worst health fears, like what happened to Ali Browne, of O’Hara, and her 7-year-old daughter, Adelaide.

Last fall, Ms. Browne’s husband was exposed to COVID-19 while he worked a second job at a country club. He had already reduced his hours due to concerns over the virus but was unable to avoid working a superspreader wedding that infected him and 40 others.

Not long after, Ms. Browne said Adelaide began showing signs of COVID, though after 24 hours of a high fever, her symptoms disappeared.

“I had thought, ‘It’s just like the media is saying; kids aren’t really that affected.’ It was a quick 24 hours, and she was fine,” Ms. Browne said in a phone interview. “And then fast forward about six weeks in November, and she had come to me in the day and said, ‘My bones ache, I don’t feel good,’ and she had spiked a high fever.”

Advertise with us

Despite a negative COVID test at the time, Adelaide became more sick over the next three days.

With bloodshot eyes that Ms. Browne recognized as a sign of a rare complication, Adelaide was rushed to the Children’s Hospital of Pittsburgh and admitted to the intensive care unit. Eventually, she was diagnosed with multisystem inflammatory syndrome in children (MIS-C), a rare condition tied to COVID.

“We are a science-based family, and I couldn’t believe as rare as everyone was saying this was, that this was happening to my very healthy, no pre-existing conditions, virtual-learner 7-year-old,” Ms. Brown said. “It was really surreal. It was scary.

“It was infuriating to hear these adults speak so definitively that this doesn’t affect children, that children can’t get that sick, when I’m staring at my healthy 7-year-old in an ICU bed, confused and sick — really sick,” Ms. Browne added.

Despite Adelaide’s experience, Ms. Browne said doctors recommended that her daughter to get the vaccine — “as soon as possible,” she added.

Advertise with us

Sarah Braham, a Bethel Park parent with children ages 9 and 11, said she would take them to get the vaccine, though she knows other parents who wouldn’t.

“There’s a split” between parents when it comes to COVID guidelines, specifically the mask rules at Bethel Park School District, Ms. Braham said.

“I know that I have friends that will not give their kids the vaccine,” she added.

In July, the FDA asked Pfizer and Moderna to expand vaccine trials to include several thousand school-age children.

Though changes to the trials made an early fall target date less likely, federal regulators said they wanted to assess whether myocarditis — an extremely rare inflammation of the heart seen in some young adults after being vaccinated — is present in younger age groups.

Advertise with us

In Pfizer’s trial, 2,300 children between the ages of 5 and 11 participated. Two-thirds of participants received the vaccine, while the rest received a salt-water placebo. The study found that children had an equivalent immune response to adults and teenagers who were protected when given two 10 milligram doses administered three weeks apart, and no cases of myocarditis were reported in the trial.

“We know that particularly the Pfizer and Moderna, in this case, the Pfizer vaccine, has tremendously great safety data and effectiveness data, and so we’re thrilled and excited that the data is being submitted, and eager that it will be just as safe and effective as it was with the older age groups,” said Dr. Todd Wolynn, CEO of Kids Plus Pediatrics, in a phone interview.

Dr. Wolynn had this to say for parents concerned about the quick vaccine rollout:

“The anti-vaccine community pushes the lie that they were rushed — the science wasn’t rushed. They’re new, but the technology for mRNA is not new, and now the vaccines are not even new. If you go back to the first studies, they’re over a year old.

“And mass vaccination is now nine months old,” Dr. Wolynn added. “So we have hundreds of millions of doses — if you look globally, billions of doses of vaccines — being given with amazing safety and effectiveness data, particularly Pfizer and Moderna.”

Advertise with us

For parents who trust the results of vaccine trials, the light at the end of the pandemic tunnel is near.

“It brings a peace of mind,” Ms. Braham said. “We are letting [the children] do activities — I do think socializing is important. It would bring a peace of mind that they are out there doing this stuff and they have a level of protection, added protection.”

Jesse Bunch: jbunch@post-gazette.com.